News
EBS
6.55
-3.68%
-0.25
Weekly Report: what happened at EBS last week (0914-0918)?
Weekly Report · 1d ago
Emergent: The MCM Engine Runs, But Naloxone Is Breaking Down
Seeking Alpha · 09/15 11:30
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
Barchart · 09/15 06:45
Emergent BioSolutions restructuring includes 90 job cuts
Seeking Alpha · 09/14 21:26
Emergent Biosolutions Highlights Global Public Health Countermeasures
TipRanks · 09/14 20:36
Weekly Report: what happened at EBS last week (0907-0911)?
Weekly Report · 09/14 09:52
Buy Rating Reaffirmed on Emergent’s Strengthened Government Contracts and Liquidity, Price Target Unchanged at $10
TipRanks · 09/09 10:55
Weekly Report: what happened at EBS last week (0831-0904)?
Weekly Report · 09/07 09:48
Emergent BioSolutions - Tough 2026 Outlook Warrant Rating Downgrade
Seeking Alpha · 09/06 17:25
Emergent BioSolutions Secures New BARDA Anthrax Contract
TipRanks · 09/01 20:36
Emergent BioSolutions announces $24M modification from BARDA
TipRanks · 09/01 12:00
Emergent BioSolutions Receives ~$24M Contract Modification From Biomedical Advanced Research And Development Authority For Strategic Preparedness Response Within U.S. Department Of Health And Human Services To Provide CYFENDUS
Benzinga · 09/01 11:56
Emergent awarded standing offer by Government of Canada for Narcan Nasal Spray
TipRanks · 08/31 12:00
Emergent BioSolutions Receives Canada's Offer To Provide NARCAN Nasal Spray, Effective Oct. 1 Through September 2029
Benzinga · 08/31 11:58
Weekly Report: what happened at EBS last week (0824-0828)?
Weekly Report · 08/31 09:53
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
Barchart · 08/31 06:55
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day
Barchart · 08/31 06:54
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
Benzinga · 08/28 16:43
Weekly Report: what happened at EBS last week (0817-0821)?
Weekly Report · 08/24 09:53
JP Morgan Reinstates Underweight on Emergent BioSolutions
Benzinga · 08/21 19:18
More
Webull provides a variety of real-time EBS stock news. You can receive the latest news about Emergent Biosolutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.